226 related articles for article (PubMed ID: 24138531)
1. Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11.
Edson KZ; Prasad B; Unadkat JD; Suhara Y; Okano T; Guengerich FP; Rettie AE
Biochemistry; 2013 Nov; 52(46):8276-85. PubMed ID: 24138531
[TBL] [Abstract][Full Text] [Related]
2. Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11.
Dhar M; Sepkovic DW; Hirani V; Magnusson RP; Lasker JM
J Lipid Res; 2008 Mar; 49(3):612-24. PubMed ID: 18065749
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 Family
Alade AN; Claw KG; McDonald MG; Prasad B; Rettie AE; Thummel KE
ACS Pharmacol Transl Sci; 2024 Mar; 7(3):716-732. PubMed ID: 38481683
[TBL] [Abstract][Full Text] [Related]
4. ω-Hydroxylation of phylloquinone by CYP4F2 is not increased by α-tocopherol.
Farley SM; Leonard SW; Taylor AW; Birringer M; Edson KZ; Rettie AE; Traber MG
Mol Nutr Food Res; 2013 Oct; 57(10):1785-93. PubMed ID: 23650179
[TBL] [Abstract][Full Text] [Related]
5. Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity.
Bardowell SA; Stec DE; Parker RS
J Nutr; 2010 Nov; 140(11):1901-6. PubMed ID: 20861217
[TBL] [Abstract][Full Text] [Related]
6. CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.
McDonald MG; Rieder MJ; Nakano M; Hsia CK; Rettie AE
Mol Pharmacol; 2009 Jun; 75(6):1337-46. PubMed ID: 19297519
[TBL] [Abstract][Full Text] [Related]
7. Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4.
Jin R; Koop DR; Raucy JL; Lasker JM
Arch Biochem Biophys; 1998 Nov; 359(1):89-98. PubMed ID: 9799565
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
Powell PK; Wolf I; Jin R; Lasker JM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440
[TBL] [Abstract][Full Text] [Related]
9. Involvement of cytochrome P450 2E1 in the (omega-1)-hydroxylation of oleic acid in human and rat liver microsomes.
Adas F; Berthou F; Picart D; Lozac'h P; Beaugé F; Amet Y
J Lipid Res; 1998 Jun; 39(6):1210-9. PubMed ID: 9643352
[TBL] [Abstract][Full Text] [Related]
10. Computational Insight Into Vitamin K
Li J; Zhang H; Liu G; Tang Y; Tu Y; Li W
Front Pharmacol; 2018; 9():1065. PubMed ID: 30319412
[TBL] [Abstract][Full Text] [Related]
11. Functional Characterization of 29 Cytochrome P450 4F2 Variants Identified in a Population of 8380 Japanese Subjects and Assessment of Arachidonic Acid
Sato Y; Hishinuma E; Yamazaki S; Ueda A; Kumondai M; Saito S; Tadaka S; Kinoshita K; Nakayoshi T; Oda A; Maekawa M; Mano N; Hirasawa N; Hiratsuka M
Drug Metab Dispos; 2023 Dec; 51(12):1561-1568. PubMed ID: 37775333
[TBL] [Abstract][Full Text] [Related]
12. Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine.
Wang MZ; Wu JQ; Bridges AS; Zeldin DC; Kornbluth S; Tidwell RR; Hall JE; Paine MF
Drug Metab Dispos; 2007 Nov; 35(11):2067-75. PubMed ID: 17709372
[TBL] [Abstract][Full Text] [Related]
13. Effect of Genetic Variability in the
Zhang JE; Klein K; Jorgensen AL; Francis B; Alfirevic A; Bourgeois S; Deloukas P; Zanger UM; Pirmohamed M
Front Pharmacol; 2017; 8():323. PubMed ID: 28620303
[TBL] [Abstract][Full Text] [Related]
14. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes.
Clarke SE; Baldwin SJ; Bloomer JC; Ayrton AD; Sozio RS; Chenery RJ
Chem Res Toxicol; 1994; 7(6):836-42. PubMed ID: 7696540
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.
Johnson AL; Edson KZ; Totah RA; Rettie AE
Adv Pharmacol; 2015; 74():223-62. PubMed ID: 26233909
[TBL] [Abstract][Full Text] [Related]
16. Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.
Hirani V; Yarovoy A; Kozeska A; Magnusson RP; Lasker JM
Arch Biochem Biophys; 2008 Oct; 478(1):59-68. PubMed ID: 18662666
[TBL] [Abstract][Full Text] [Related]
17. Characterization of three cytochrome P450s purified from renal microsomes of untreated male rats and comparison with human renal cytochrome P450.
Imaoka S; Nagashima K; Funae Y
Arch Biochem Biophys; 1990 Feb; 276(2):473-80. PubMed ID: 2306108
[TBL] [Abstract][Full Text] [Related]
18. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
[TBL] [Abstract][Full Text] [Related]
19. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical quantification of cynomolgus CYP2J2, CYP4A and CYP4F enzymes in liver and small intestine.
Uehara S; Murayama N; Nakanishi Y; Nakamura C; Hashizume T; Zeldin DC; Yamazaki H; Uno Y
Xenobiotica; 2015 Feb; 45(2):124-30. PubMed ID: 25138712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
